The Cooper Companies, Inc.
COO
Peringkat dalam Saham
#1887
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Harga Saham
$59.03
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$11.23B
Perubahan (1 hari)
1.50%
Perubahan (1 tahun)
-21.29%
Negara
US
Perdagangan The Cooper Companies, Inc. (COO)
Kategori
Healthcare
Rasio P/E untuk The Cooper Companies, Inc. (COO)
Rasio P/E per October 2026 TTM: 18.73
Menurut laporan keuangan dan harga saham terbaru dari The Cooper Companies, Inc., rasio P/E saat ini (TTM) adalah 18.73. Pada akhir 2024, perusahaan memiliki rasio P/E sebesar 53.07.
Riwayat rasio P/E untuk The Cooper Companies, Inc. dari 2000 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | 18.73 | -49.78% |
| 2025 | 37.30 | -29.73% |
| 2024 | 53.07 | 1.18% |
| 2023 | 52.45 | 50.14% |
| 2022 | 34.94 | 1,878.19% |
| 2021 | 1.77 | -89.25% |
| 2020 | 16.43 | 113.76% |
| 2019 | 7.69 | -66.09% |
| 2018 | 22.67 | 187.78% |
| 2017 | 7.88 | 1.07% |
| 2016 | 7.79 | -14.15% |
| 2015 | 9.08 | 24.40% |
| 2014 | 7.30 | 37.62% |
| 2013 | 5.30 | 14.51% |
| 2012 | 4.63 | -0.07% |
| 2011 | 4.63 | -7.35% |
| 2010 | 5.00 | 59.02% |
| 2009 | 3.14 | 11.08% |
| 2008 | 2.83 | -106.75% |
| 2007 | -41.94 | -533.01% |
| 2006 | 9.69 | 25.13% |
| 2005 | 7.74 | 27.19% |
| 2004 | 6.09 | 23.42% |
| 2003 | 4.93 | 18.96% |
| 2002 | 4.15 | -13.54% |
| 2001 | 4.79 | 9.50% |
| 2000 | 4.38 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 47.48 | 153.52% |
US
|
|
| 27.43 | 46.42% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 203.76% |
US
|
|
| - | - |
CH
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.